PHBI Pharmagreen Biotech Inc.
Fundamentals / CIK 0001435181 / USDPharmagreen Biotech Inc. reported $140K in total assets and a net loss of $501K through September 30, 2022 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PHBI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2022-- Sep 30, 2022
-
Operating Income FY 2022-$649K Operating profit
-
Net Income FY 2022-$501K GAAP bottom line
-
Diluted EPS FY 2022-- Split-adjusted
-
Free Cash Flow FY 2022-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2023$5.3K Total debt: --
Annual revenue and net income
5 fiscal years (2018 to 2022), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Research & Development | -- | -- | -- | $4.0K | $7.6K |
| Total Operating Expenses | $1.10M | $744K | $486K | $642K | $749K |
| Operating Income | -$1.10M | -$744K | -$486K | -$642K | -$749K |
| Interest Expense | $29K | $681K | $299K | $3.8K | -- |
| Income Before Tax | -- | -- | -$2.48M | -$769K | -- |
| Income Tax Expense | $0 | $0 | $0 | -- | -- |
| Net Income | -$876K | -$4.53M | -$2.48M | -$768K | -$1.07M |
| Basic EPS | -- | -$0.02 | -$0.03 | -$0.01 | -$0.04 |
| Diluted EPS | -- | -$0.02 | -$0.03 | -$0.01 | -$0.04 |
| Basic Shares Outstanding | 403.7M | 293.7M | 82.1M | 74.1M | 24.8M |
| Diluted Shares Outstanding | 218.7M | 326.0M | 388.4M | 364.9M | 293.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $597 | $963 | -- | -- | $0 | $0 | -- | -- |
| Cost of Revenue | $389 | $985 | -- | -- | $0 | $0 | -- | -- |
| Gross Profit | $208 | -$22 | -- | -- | $0 | $0 | -- | -- |
| Total Operating Expenses | $82K | $120K | $181K | $198K | $241K | $459K | $204K | $273K |
| Operating Income | -$82K | -$188K | -$181K | -$198K | -$241K | -$1.04M | -$204K | -$273K |
| Interest Expense | $8.2K | $8.1K | $8.3K | -$2.1K | $11K | $10K | $10K | $7.6K |
| Net Income | -$163K | -$188K | -$39K | -$110K | $252K | -$1.04M | $19K | -$831K |
| Basic EPS | -- | -- | -- | -- | $0.00 | -- | $0.00 | -- |
| Diluted EPS | -- | -- | -- | -- | $0.00 | -- | $0.00 | -- |
| Basic Shares Outstanding | -- | -- | -- | -- | 406.6M | 394.4M | 384.2M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 613.5M | -- | -- | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.0K | $25K | $12K | $63K | $152K |
| Cash & Short-Term Investments | $8.0K | $25K | $12K | $63K | $152K |
| Accounts Receivable, Net | $383 | $290 | -- | -- | -- |
| Inventory | $0 | -- | -- | -- | -- |
| Total Current Assets | $209K | -- | $266K | $189K | $198K |
| Property, Plant & Equipment, Net | -- | -- | -- | $441K | $251K |
| Total Non-Current Assets | $0 | -- | $0 | $441K | $251K |
| Total Assets | $209K | $373K | $266K | $630K | $449K |
| Accounts Payable | $645K | $580K | $455K | $830K | $590K |
| Total Current Liabilities | $1.91M | $2.03M | $3.17M | $1.46M | $1.84M |
| Long-Term Debt | -- | -- | $30K | -- | -- |
| Total Non-Current Liabilities | $119K | $39K | $33K | $1.6K | $693 |
| Total Liabilities | $2.03M | $2.07M | $3.20M | $1.46M | $1.84M |
| Total Debt (incl. Leases) | -- | -- | $30K | -- | -- |
| Common Stock | $442K | $381K | $96K | $76K | $72K |
| Retained Earnings | -$12.57M | -$11.70M | -$7.17M | -$4.73M | -$3.96M |
| Accumulated Other Comp. Income | $94K | -$8.4K | $37K | $48K | $39K |
| Total Stockholders' Equity | -$1.78M | -$1.69M | -$2.93M | -$834K | -$1.39M |
| Total Equity | -$1.82M | -$1.69M | -$2.93M | -$834K | -$834K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.3K | $7.4K | $25K | $8.0K | $24K | $3.0K | $10K | $25K |
| Cash & Short-Term Investments | $5.3K | $7.4K | $25K | $8.0K | $24K | $3.0K | $10K | $25K |
| Accounts Receivable, Net | $606 | $569 | $465 | $383 | $316 | $70 | -- | $290 |
| Inventory | $9.2K | $9.5K | -- | $0 | -- | -- | -- | -- |
| Total Current Assets | $51K | $74K | -- | $209K | -- | -- | -- | -- |
| Total Non-Current Assets | $89K | $89K | -- | $0 | -- | -- | -- | -- |
| Total Assets | $140K | $163K | $212K | $209K | $191K | $198K | $358K | $373K |
| Accounts Payable | $697K | $691K | $685K | $645K | $622K | $623K | $611K | $580K |
| Total Current Liabilities | $2.17M | $2.06M | $1.92M | $1.91M | $1.99M | $2.56M | $1.90M | $2.03M |
| Total Non-Current Liabilities | $120K | $91K | $91K | $119K | $138K | $44K | $41K | $39K |
| Total Liabilities | $2.29M | $2.15M | $2.01M | $2.03M | $2.13M | $2.60M | $1.94M | $2.07M |
| Common Stock | $464K | $455K | $455K | $442K | $424K | $397K | $385K | $381K |
| Retained Earnings | -$12.97M | -$12.80M | -$12.61M | -$12.57M | -$12.46M | -$12.72M | -$11.68M | -$11.70M |
| Accumulated Other Comp. Income | $48K | $79K | $82K | $94K | $13K | -$28K | -$11K | -$8.4K |
| Total Stockholders' Equity | -$2.10M | -$1.94M | -$1.75M | -$1.78M | -$1.89M | -$2.40M | -$1.58M | -$1.69M |
| Total Equity | -$2.15M | -$1.99M | -$1.80M | -$1.82M | -$1.94M | -$2.40M | -$1.58M | -$1.69M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Net Income | -$876K | -$4.53M | -$2.48M | -$769K | -$1.07M |
| Change in Receivables | -$93 | $5 | -- | -- | -- |
| Change in Payables | -- | -- | $293K | -- | -- |
| Operating Cash Flow | -$427K | -$206K | -$608K | -$318K | -$786K |
| Capital Expenditure | -- | -- | -- | -$196K | -$251K |
| Free Cash Flow | -- | -- | -- | -$514K | -$1.04M |
| Investing Cash Flow | -- | -- | -- | -$196K | -$251K |
| Common Stock Issued | -- | -- | $570K | $75K | $298K |
| Financing Cash Flow | $314K | $257K | $563K | $433K | $1.12M |
| Net Change in Cash | -$17K | $13K | -$50K | -$89K | $135K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$163K | -$267K | $39K | -$110K | $252K | -$998K | -$19K | -$831K |
| Change in Receivables | $409 | -$104 | -$82 | -$119 | -$194 | -$8 | $228 | -- |
| Operating Cash Flow | $7.5K | -$34K | -$19K | -$92K | -$130K | -$56K | -$149K | -$55K |
| Common Stock Issued | $0 | $0 | $0 | -- | -$6.5K | $26K | $92K | -- |
| Financing Cash Flow | $18K | $19K | $47K | $0 | $113K | $65K | $136K | $37K |
| Net Change in Cash | -$2.1K | -$18K | $17K | -$16K | $21K | -$7.4K | -$15K | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|
| Return on Assets (ROA) | -419.0% | -1214.8% | -932.5% | -121.8% | -238.9% |
| Current Ratio | 0.11x | -- | 0.08x | 0.13x | 0.11x |
| Quick Ratio | 0.11x | 0.01x | 0.00x | 0.04x | 0.08x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -356.9% | -52.7% | -441.1% | -419.0% | -835.1% | -1003.4% | -1145.0% | -1214.8% |
| Current Ratio | 0.02x | 0.04x | -- | 0.11x | -- | -- | -- | -- |
| Quick Ratio | 0.02x | 0.03x | 0.01x | 0.11x | 0.01x | 0.00x | 0.01x | 0.01x |
| Net Income Growth (YoY) | -164.7% | -- | -310.3% | -- | -- | -- | -- | -- |